Market Place
Sourcing Support
Impact Therapeutics Entered into Global Partnership with Eikon Therapeutics
01 Jun 2023 //
PR NEWSWIRE
FDA Granted Orphan Drug Designation to IMP4297+TMZ for SCLC
19 Aug 2022 //
GLOBENEWSWIRE
Impact Therapeutics Announces Completion of Series D1 Financing
14 Mar 2022 //
PRNEWSWIRE
Burning Rock, IMPACT Collaborate to Provide Testing Services for IMP9064
03 Nov 2021 //
GLOBENEWSWIRE
IMPACT Therapeutics Announced ATR Inhibitor IMP9064 IND Clearance by FDA
29 Oct 2021 //
PRNEWSWIRE
IMPACT Therapeutics Appoints Dr. Chun-Pyn Shen as Head of Regulatory Affairs
30 Sep 2021 //
PRNEWSWIRE
Cyclica & IMPACT Team Up to Advance Differentiated Anti-cancer Drug Development
22 Sep 2021 //
BUSINESSWIRE
Impact Therapeutics Announced First-Patient-Dose of Wee1 Inhibitor IMP7068
10 Mar 2021 //
PRNEWSWIRE
Impact Announced First-Patient-Dose of Wee1 Inhibitor IMP7068
10 Mar 2021 //
PRNASIA
Junshi Biosciences and Impact Therapeutics Establish Joint Venture
20 Aug 2020 //
GLOBENEWSWIRE
Alexion`s neuro bet, Rubius` trial troubles and biotech`s gene therapy
14 Jan 2020 //
BIO PHARMA DIVE
FDA Approves First Myelofibrosis Drug in Nearly a Decade
16 Aug 2019 //
BIOSPACE
Celgene wins approval for drug key to Bristol buyout
16 Aug 2019 //
BIOPHARMADIVE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.